1,465
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Fries, lies and alibis: the impact of methamphetamine use on moral values and moral conduct

Received 15 Aug 2023, Accepted 30 Jan 2024, Published online: 11 Feb 2024

References

  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Text Revision. Washington (DC): American Psychiatric Publishing.
  • Bax T. 2021a. The adverse childhood experiences of methamphetamine users in Aotearoa/New Zealand. International Journal of Criminology and Sociology. 10:1430–1442.
  • Bax T. 2021b. The life course of methamphetamine users in Aotearoa/New Zealand: school, friendship and work. Journal of Criminology. 54(4):425–447. doi:10.1177/26338076211017180.
  • Bax T. 2023. “I had no problems and just felt so fabulous”: the “storylines” of methamphetamine initiation in Aotearoa/New Zealand. Journal of Drug Issues. 53(3):499–516. doi:10.1177/00220426221134903.
  • Bax T. 2024. People seeking wellness: the physical, mental, spiritual and family health of people in Aotearoa-New Zealand who desisted from methamphetamine use. International Journal of Criminal Justice, forthcoming.
  • Boeri M, Harbry L, Gibson D. 2009. A qualitative exploration of trajectories among suburban users of methamphetamine. Journal of Ethnographic & Qualitative Research. 3:139–151.
  • Boeri M, Whalen T. 2009. Older drug users: a life course study of turning points in drug use, 2009-2010. Inter-University Consortium for Political and Social Research.
  • Boshears P, Boeri M, Harbry L. 2011. Addiction and sociality: perspectives from methamphetamine users in suburban USA. Addiction Research and Theory. 19(4):289–301. doi:10.3109/16066359.2011.566654.
  • Boyd S, Carter C. 2010. Methamphetamine discourse: media, law, and policy. Canadian Journal of Communication. 35(2):219–238. doi:10.22230/cjc.2010v35n2a2207.
  • Brecht M, Greenwell L, Anglin M. 2007. Substance use pathways to methamphetamine use among treated users. Addictive Behaviors. 32:24–38. doi:10.1016/j.addbeh.2006.03.017.
  • Brecht M, O’Brien A, von Mayrhauser C, Anglin M. 2004. Methamphetamine use behaviors and gender differences. Addictive Behaviors. 29(1):89–106. doi:10.1016/S0306-4603(03)00082-0.
  • Butler R, Wheeler A, Sheridan J. 2010. Physical and psychological harms and health consequences of methamphetamine use amongst a group of New Zealand users. International Journal of Mental Health & Addiction. 8(3):432–443. doi:10.1007/s11469-009-9213-5.
  • Carbone-Lopez K, Gatewood Owens J, Miller J. 2012. Women’s “storylines” of methamphetamine initiation in the Midwest. Journal of Drug Issues. 42(3):226–246. doi:10.1177/0022042612456013.
  • Carton T. 2016. The war on P (pure, methamphetamine) in New Zealand, a moral-panic? Sociology Mind. 6:92–106. doi:10.4236/sm.2016.63008.
  • Cheng S, Garfein R, Semple S, Strathdee S, Zians J, Patterson T. 2010. Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego. Substance Use & Misuse. 45(1-2):116–133. doi:10.3109/10826080902869620.
  • Christian D, Huber A, Brecht M, McCann M, Marinelli-Casey P, Lord R, Reiber C, Lu T-H, Galloway G. 2007. Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample. Substance Use & Misuse. 42(14):2207–2222. doi:10.1080/10826080701209341.
  • Clausen J. 1993. American lives: looking back at the children of the great depression. New York: The Free Press.
  • Cohn A, O’Connor R, Lancaster K, Rawstorne P, Nathan S. 2020. Media and political framing of crystal methamphetamine use in Australia. Drugs: Education, Prevention and Policy. 27(4):261–270. doi:10.1080/09687637.2019.1679089.
  • Darke S, Kaye S, McKetin R, Duflou J. 2008. Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review. 27(3):253–262. doi:10.1080/09595230801923702.
  • Deen H, Kershaw S, Newton N, Stapinski L, Birrell L, Debenham J, Champion K, Kay-Lambkin F, Teesson M, Chapman C. 2021. Stigma, discrimination and crystal methamphetamine (‘ice’): current attitudes in Australia. International Journal of Drug Policy. 87:102982. doi:10.1016/j.drugpo.2020.102982.
  • Degenhardt L, Sara G, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall W. 2017. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug and Alcohol Review. 36(2):160–170. doi:10.1111/dar.12426.
  • Dodes L, Dodes Z. 2014. The Sober truth. Debunking the bad science behind 12-step programs and the Rehab Industry. Boston: Beacon Press.
  • Durrant R, Fisher S, Thun M. 2011. Understanding punishment responses to drug offenders: the role of social threat, individual harm, moral wrongfulness, and emotional warmth. Contemporary Drug Problems. 38:147–177. doi:10.1177/009145091103800107.
  • Fede S, Harenski C, Schaich Borg J, Sinnott-Armstrong W, Rao V, Caldwell B, Nyalakanti P, Koenigs M, Decety J, Calhoun V, Kiehl K. 2005. Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing. Psychopharmacology. 233:3077–3087. doi:10.1007/s00213-016-4344-4.
  • Fergusson D, Horwood L, Ridder E. 2005. Show me the child at seven: the consequences of conduct problems in childhood for psychosocial functioning in adulthood. The Journal of Child Psychology and Psychiatry. 46:837–849. doi:10.1111/j.1469-7610.2004.00387.x.
  • Flanagan O. 2013. The shame of addiction. Frontiers in Psychiatry. 4:1–11. doi:10.3389/fpsyt.2013.00120.
  • Ford J, Russo E. 2006. Trauma-focused, present-centered, emotional self-regulation approach to integrated treatment for posttraumatic stress and addiction: trauma adaptive recovery group education and therapy (TARGET). American Journal of Psychotherapy. 60(4):335–355. doi:10.1176/appi.psychotherapy.2006.60.4.335.
  • Foulds J, Boden J, McKetin R, Newton-Howes G. 2020. Methamphetamine use and violence: findings from a longitudinal birth cohort. Drug and Alcohol Dependence. 207(1):1–7.
  • Fox H, Axelrod S, Paliwal P, Sleeper J, Sinha R. 2007. Difficulties in emotion regulation and impulse control during cocaine abstinence. Drug and Alcohol Dependence. 89(2-3):298–301.
  • Frank L, Nagel S. 2017. Addiction and moralization: the role of the underlying model of addiction. Neuroethics. 10:129–139. doi:10.1007/s12152-017-9307-x.
  • Fredrickson A, Farren Gibson A, Lancaster K, Nathan S. 2019. “Devil’s Lure took all i had”: moral panic and the discursive construction of crystal methamphetamine in Australian News Media. Contemporary Drug Problems. 46(1):105–121. doi:10.1177/0091450918823340.
  • Freud S. 1949. The ego and the id. London: The Hogarth Press Ltd.
  • Giele J, Elder G. 1998. Life course research. Development of a field. In: Giele JZ, Elder GH, editors. Methods of life course research: qualitative and quantitative approaches. Thousand Oaks, CA: Sage Publications; p. 5–27.
  • Gizzi M, Gerkin P. 2010. Methamphetamine use and criminal behavior. International Journal of Offender Therapy and Comparative Criminology. 54(6):915–936. doi:10.1177/0306624X09351825.
  • Halkitis P, Fischgrund B, Parsons J. 2005. Explanations for methamphetamine use among gay and bisexual men in New York City. Substance Use & Misuse. 40:1331–1345. doi:10.1081/JA-200066900.
  • Hart C, Marvin C, Silver R, Smith E. 2012. Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology. 37:586–608. doi:10.1038/npp.2011.276.
  • Homer B, Solomon T, Moeller R, Mascia A, DeRaleau L, Halkitis P. 2008. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychological Bulletin. 134(2):301–310. doi:10.1037/0033-2909.134.2.301.
  • Hser Y, Longshore D, Anglin M. 2007. The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Evaluation Review. 31(6):515–547.
  • Joe K. 1996. The lives and times of Asian-Pacific American women drug users: an ethnographic study of their methamphetamine use. Journal of Drug Issues. 26(1):199–218. doi:10.1177/002204269602600111.
  • Johanson C-E, Frey K, Lundahl L, Keenan P, Lockhart N, Roll J, Galloway G, Koeppe R, Kilbourn M, Robbins T, Schuster C. 2006. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology. 185:327–338. doi:10.1007/s00213-006-0330-6.
  • Kim Y, Kwon D, Chang Y. 2011. Impairments of facial emotion recognition and theory of mind in methamphetamine abusers. Psychiatry Research. 186:80–84. doi:10.1016/j.psychres.2010.06.027.
  • Lapsley D, Stey P. 2011. Id, ego, and superego. In: V.S. Ramachandran, editor. Encyclopedia of human behavior. London: Elsevier; p. 393–399.
  • Lende D, Leonard T, Sterk C, Elifson K. 2007. Functional methamphetamine use: the insider’s perspective. Addiction Research and Theory. 15(5):465–477. doi:10.1080/16066350701284552.
  • Lewis M. 2011. Memoirs of an addicted brain. A neuroscientist examines his former life on drugs. New York: PublicAffairs.
  • Lewis M. 2015. The biology of desire: why addiction is not a disease. New York: PublicAffairs.
  • Lewis M. 2017. Addiction and the brain: development, not disease. Neuroethics. 10:7–18. doi:10.1007/s12152-016-9293-4.
  • Lynskey M, Fergusson D. 1995. Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use. Journal of Abnormal Child Psychology. 23(3):281–302.
  • McKetin R, Boden J, Foulds J, Najman J, Ali R, Degenhardt L, Baker A, Ross J, Farrell M, Weatherburn D. 2020. The contribution of methamphetamine use to crime: evidence from Australian longitudinal data. Drug and Alcohol Dependence. 216(1):108262. doi:10.1016/j.drugalcdep.2020.108262.
  • McKetin R, Hickey K, Devlin K, Lawrence K. 2010. The risk of psychotic symptoms associated with recreational methamphetamine use. Drug and Alcohol Review. 29:358–363. doi:10.1111/j.1465-3362.2009.00160.x.
  • McKetin R, Lubman D, Najman J, Dawe S, Butterworth P, Baker A. 2014. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction. 109:798–806. doi:10.1111/add.12474.
  • McKetin R, McLaren J, Kelly E. 2005. The Sydney methamphetamine market: patterns of supply, use, personal harms and social consequences, NDLERF Monograph No. 13. Sydney: National Drug and Alcohol Research Centre, University of NSW.
  • McKetin R, McLaren J, Kelly E, Lubman D, Hides L. 2006. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 101(10):1473–1478. doi:10.1111/j.1360-0443.2006.01496.x.
  • McKetin R, Sutherland R, Peacock A, Farrell M, Degenhardt L. 2021. Patterns of smoking and injecting methamphetamine and their association with health and social outcomes. Drug and Alcohol Review. 40:1256–1265. doi:10.1111/dar.13364.
  • Messina N, Marinelli-Casey P, Hillhouse M, Rawson R, Hunter J, Ang A. 2008. Childhood adverse events and methamphetamine use among men and women. Journal of Psychoactive Drugs. 40(SARC Supplement 5):399–409. doi:10.1080/02791072.2008.10400667.
  • Morse S. 2004. Medicine and morals, craving and compulsion. Substance Use & Misuse. 39(3):437–460. doi:10.1081/JA-120029985.
  • Neale J, Nettleton S, Pickering L. 2011. Recovery from problem drug use: what can we learn from the sociologist Erving Goffman? Drugs: education, prevention and policy. 18(1):3–9. doi:10.3109/09687631003705546.
  • O’Brien A, Brecht M, Casey C. 2008. Narratives of methamphetamine abuse: a qualitative exploration of social, psychological, and emotional experiences. Journal of Social Work Practice in the Addictions. 8(3):343–366. doi:10.1080/15332560802224469.
  • Paulus M, Hozack N, Zauscher B, Frank L, Brown G, Braff D, Schuckit MA. 2002. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology. 26(1):53–63. doi:10.1016/S0893-133X(01)00334-7.
  • Peele S, Rhoads Z. 2019. Outgrowing addiction: with common sense instead of “disease” therapy. Hinesburg, Vermont: Upper Access Books.
  • Policy Advisory Group. 2009. Tackling methamphetamine: an action plan. Wellington: Department of the Prime Minister and Cabinet.
  • Rasmussen N. 2008. On speed: from benzedrine to adderall. New York: University Press.
  • Rawson R, Washton A, Domier C, Reiber C. 2002. Drugs and sexual effects: role of drug type and gender. Journal of Substance Abuse Treatment. 22:103–108. doi:10.1016/S0740-5472(01)00215-X.
  • Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, et al. 2006. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry. 63(1):90–100. doi:10.1001/archpsyc.63.1.90.
  • Semple S, Patterson T, Grant I. 2003. Binge use of methamphetamine among HIV-positive men who have sex with men: Pilot data and HIV prevention implications. AIDS Education and Prevention. 15:133–147. doi:10.1521/aeap.15.3.133.23835.
  • Sexton R, Carlson R, Leukefeld C, Booth B. 2006. Methamphetamine use and adverse consequences in the rural southern united states: an ethnographic overview. Journal of Psychoactive Drugs. 38(sup3):393–404. doi:10.1080/02791072.2006.10400603.
  • Sheridan J, Butler R, Wheeler A. 2009. Initiation into methamphetamine use: qualitative findings from an exploration of first time use among a group of New Zealand Users. Journal of Psychoactive Drugs. 41(1):11–17. doi:10.1080/02791072.2009.10400670.
  • Sommers I, Baskin D. 2006. Methamphetamine use and violence. Journal of Drug Issues. 36(1):77–96. doi:10.1177/002204260603600104.
  • Sommers I, Baskin D, Baskin-Sommers A. 2006. Methamphetamine use among young adults: health and social consequences. Addictive Behaviors. 31(8):1469–1476. doi:10.1016/j.addbeh.2005.10.004.
  • Szalavitz M. 2016. The unbroken brain: a revolutionary way of understanding addiction. New York: St Martin’s Press.
  • Volkow N, Koob G, McLellan T. 2016. Neurobiological advances from the brain disease model of addiction. The New England Journal of Medicine. 374(4):363–371. doi:10.1056/NEJMra1511480.
  • Waldorf D, Reinarman C, Murphy S. 1991. Cocaine changes: the experience of using and quitting. Philadelphia: Temple University Press.
  • Wallace C, Galloway T, McKetin R, Kelly E, Leary J. 2009. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia. Drug and Alcohol Review. 28(6):592–599. doi:10.1111/j.1465-3362.2008.00016.x.
  • Weidner R. 2009. Methamphetamine in three small midwestern cities: evidence of a moral panic. Journal of Psychoactive Drugs. 41(3):227–239. doi:10.1080/02791072.2009.10400533.
  • Wilkins C, Prasad J, Wong K, Rychert M. 2015. Recent trends in illegal drug use in New Zealand, 2006-2014. Findings from the illicit drug monitoring system. Auckland: SHORE and Whariki Research Centre, College of Health, Massey University.
  • Wilkins C, Prasad J, Wong K, Rychert M. 2017. Recent trends in illegal drug use in New Zealand, 2006-2016. Findings from the illicit drug monitoring system. Auckland: SHORE and Whariki Research Centre, College of Health, Massey University.
  • Witkiewitz K, Bowen S, Douglas H, Hsu SH. 2013. Mindfulness-based relapse prevention for substance craving. Addictive Behaviors. 38(2):1563–1571. doi:10.1016/j.addbeh.2012.04.001.
  • Zweben J, Cohen J, Christian D, Galloway G, Salinardi M, Parent D, Iguchi M. 2004. Psychiatric symptoms in methamphetamine users. American Journal on Addictions. 13(2):181–190. doi:10.1080/10550490490436055.